. Author manuscript; available in PMC: 2014 Nov 1.

Published in final edited form as: J Acquir Immune Defic Syndr. 2013 Nov 1;64(3):254–260. doi: 10.1097/QAI.0b013e3182a60e82

Table 3. Adjusted absolute and percent change in triglyceride values comparing fish oil to other therapies^a^,^b.

Characteristics	TG Change (95% CI)	P value	% change	P value
Fenofibrate vs. Fish oil	-49 (-108, 11)	0.11	-16 (-31, 0)	0.04
Gemfibrozil vs. Fish oil	-80 (-150, -10)	0.02	-19 (-37, -1)	0.04
Gemfibrozil or fenofibrate vs. Fish oil	-60 (-114, -5)	0.03	-17 (-31, -3)	0.02
Atorvastatin vs. Fish oil	-33 (-81, 15)	0.18	-4 (-16, 9)	0.56

Adjusted for age, sex, race, baseline CD4⁺ cell count, diabetes, body mass index, protease inhibitor use, and time between triglyceride measures

Restricted to baseline TG value >150 mg/dl and <810 mg/dl

Table 3. Adjusted absolute and percent change in triglyceride values comparing fish oil to other therapiesa,b.